Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Chronic Glaucoma Induced in Rats by a Single Injection of Fibronectin-Loaded PLGA Microspheres: IOP-Dependent and IOP-Independent Neurodegeneration

  • Munuera, Ines
  • Aragon-Navas, Alba
  • Villacampa, Pilar
  • Gonzalez-Cela, Miriam A.
  • Subías, Manuel
  • Pablo, Luis E.
  • Garcia-Feijoo, Julian
  • Herrero-Vanrell, Rocio
  • Garcia-Martin, Elena
  • Bravo-Osuna, Irene
  • Rodrigo, Maria J.
To evaluate a new animal model of chronic glaucoma induced using a single injection of fibronectin-loaded biodegradable PLGA microspheres (Ms) to test prolonged therapies. 30 rats received a single injection of fibronectin-PLGA-Ms suspension (MsF) in the right eye, 10 received non-loaded PLGA-Ms suspension (Control), and 17 were non-injected (Healthy). Follow-up was performed (24 weeks), evaluating intraocular pressure (IOP), optical coherence tomography (OCT), histology and electroretinography. The right eyes underwent a progressive increase in IOP, but only induced cohorts reached hypertensive values. The three cohorts presented a progressive decrease in ganglion cell layer (GCL) thickness, corroborating physiological age-related loss of ganglion cells. Injected cohorts (MsF > Control) presented greater final GCL thickness. Histological exams explain this paradox: the MsF cohort showed lower ganglion cell counts but higher astrogliosis and immune response. A sequential trend of functional damage was recorded using scotopic electroretinography (MsF > Control > Healthy). It seems to be a function–structure correlation: in significant astrogliosis, early functional damage can be detected by electroretinography, and structural damage can be detected by histological exams but not by OCT. Males presented higher IOP and retinal and GCL thicknesses and lower electroretinography. A minimally invasive chronic glaucoma model was induced by a single injection of biodegradable Ms.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Laponite for biomedical applications: An ophthalmological perspective

  • Rodrigo, María J.
  • Cardiel, María J.
  • Fraile, José M.
  • Mayoral, José A.
  • Pablo, Luis E.
  • García-Martin, Elena
Clay minerals have been applied in biomedicine for thousands of years. Laponite is a nanostructured synthetic clay with the capacity to retain and progressively release drugs. In recent years there has been a resurgence of interest in Laponite application in various biomedical areas. This is the first paper to review the potential biomedical applications of Laponite in ophthalmology. The introduction briefly covers the physical, chemical, rheological, and biocompatibility features of different routes of administration. After that, emphasis is placed on 1) drug delivery for antibiotics, anti-inflammatories, growth factors, other proteins, and cancer treatment; 2) bleeding prevention or treatment; and 3) tissue engineering through regenerative medicine using scaffolds in intraocular and extraocular tissue. Although most scientific research is not performed on the eye, both the findings and the new treatments resulting from that research are potentially applicable in ophthalmology since many of the drugs used are the same, the tissue evaluated in vitro or in vivo is also present in the eye, and the pathologies treated also occur in the eye. Finally, future prospects for this emerging field are discussed.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Multi-loaded PLGA microspheres as neuroretinal therapy in a chronic glaucoma animal model

  • Aragón-Navas, Alba
  • Rodrigo, Maria Jesus
  • Munuera, Inés
  • García-Herranz, David
  • Subías, Manuel
  • Villacampa, Pilar
  • García-Feijoo, Julián
  • Pablo, Luis
  • Garcia-Martin, Elena
  • Herrero-Vanrell, Rocio
  • Bravo-Osuna, Irene
This work focused on the co-encapsulation and simultaneous co-delivery of three different neuroprotective drugs in PLGA (poly(lactic-co-glycolic acid) microspheres for the treatment of glaucoma. For formulation optimization, dexamethasone (anti-inflammatory) and ursodeoxycholic acid (anti-apoptotic) were co-loaded by the solid-in-oil-in-water emulsion solvent extraction-evaporation technique as a first step. The incorporation of a water-soluble co-solvent (ethanol) and different amounts of dexamethasone resulted critical for the encapsulation of the neuroprotective agents and their initial release. The optimized formulation was obtained with 60 mg of dexamethasone and using an 80:20 dichloromethane:ethanol ratio. In the second step in the microencapsulation process, the incorporation of the glial cell line-derived neurotrophic factor (GDNF) was performed. The final prototype showed encapsulation efficiencies for each component above 50% with suitable properties for long-term application for at least 3 months. Physicochemical studies were performed by SEM, TEM, DSC, XRD, and gas chromatography. The evaluation of the kinetic release by the Gallagher-Corrigan analysis with Gorrasi correction helped to understand the influence of the co-microencapsulation on the delivery of the different actives from the optimized formulation. The final prototype was tested in a chronic glaucoma animal model. Rats received two intravitreal injections of the neuroprotective treatment within a 24-week follow-up study. The proposed formulation improved retinal ganglion cell (RGC) functionality examined by electroretinography. Also, it was able to maintain a neuroretinal thickness similar to that of healthy animals scanned by in vivo optical coherence tomography, and a higher RGC count on histology compared to glaucomatous animals at the end of the study.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma

  • González-Cela-Casamayor, Ana
  • Rodrigo, María J.
  • Miriam
  • Brugnera, Marco
  • Munuera, Inés
  • Martínez-Rincón, Teresa
  • Prats-Lluís, Catalina
  • Villacampa, Pilar
  • García-Feijoo, Julián
  • Pablo, Luis E.
  • Bravo-Osuna, Irene
  • Garcia-Martin, Elena
  • Herrero-Vanrell, Rocío
Glaucoma is a multifactorial neurodegenerative disease that affects the retina and optic nerve. The aim of this work was to reach different therapeutics targets by co-encapsulating three neuroprotective substances with hypotensive (latanoprost), antioxidant (melatonin) and anti-inflammatory (ketorolac) activity in biodegradable poly (lactic-co-glycolic acid) (PLGA) microspheres (MSs) capable of releasing the drugs for months after intravitreal injection, avoiding the need for repeated administrations. Multi-loaded PLGA MSs were prepared using the oil-in-water emulsion solvent extraction-evaporation technique and physicochemically characterized. PLGA 85:15 was the polymer ratio selected for the selected formulation. Tri-loaded MSs including vitamin E as additive showed good tolerance in retinal pigment epithelium cells after 24 h exposure (>90% cell viability). The final formulation (KMLVE) resulted in 33.58 ± 5.44 µm particle size and drug content (µg/mg MSs) of 39.70 ± 5.89, 67.28 ± 4.17 and 7.51 ± 0.58 for melatonin, ketorolac and latanoprost respectively. KMLVE were able to release in a sustained manner the three drugs over 70 days. KMLVE were injected at 2 and 12 weeks in Long-Evans rats (n = 20) after the induction of chronic glaucoma. Ophthalmological tests were performed and compared to not treated glaucomatous (n = 45) and healthy (n = 17) animals. Treated glaucomatous rats reached the lowest intraocular pressure, enhanced functionality of bipolar and retinal ganglion cells and showed greater neuroretinal thickness by optical coherence tomography (p < 0.05) compared to not treated glaucomatous rats at 24 weeks follow-up. According to the results, the tri-loaded microspheres can be considered as promising controlled-release system for the treatment of glaucoma.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Clues to prognosis in anterior ischemic optic neuropathy: an optical coherence tomography angiography study

  • Rodrigo, Maria J.
  • Pérez-Gómez, Pablo
  • Fuertes, Isabel
  • Pablo, Luis E.
  • Subías, Manuel
  • Casanovas-Marsal, Josep O.
  • Garcia-Martin, Elena
AIM: To investigate optic nerve vascularization in patients with anterior ischemic optic neuropathy (AION) during the first 3mo after onset, using comprehensive ophthalmic assessments combined with optical coherence tomography (OCT) and optical coherence tomography angiography (OCT-A). METHODS: A prospective longitudinal observational study was performed with a 3-month follow-up. Clinical data recorded included age, sex, laterality of ocular involvement, AION subtype, previous history of ischemic events, cardiovascular risk factors such as high blood pressure, dyslipidemia, diabetes mellitus, smoking status, obstructive sleep apnea, and systemic treatments received. Functional, structural, and vascular examinations, including best corrected visual acuity (BCVA), visual field, OCT, and OCT-A, were performed at baseline, 1, and 3mo. RESULTS: Twenty-two subjects included 12 patients with AION and 10 healthy controls were enrolled. Mean age was 63.75±8.32y in the AION group and 61.80±5.04y in the control group (P=0.365). Gender and laterality distributions were comparable. AION patients showed significantly decreased optic nerve head perfusion at baseline (P=0.024) and 1mo (P=0.033). OCT revealed early thickening and subsequent atrophy of the peripapillary retinal nerve fiber layer and macular layers. OCT-A vascular parameters correlated significantly with 1-month BCVA (r=0.800, P≤0.05) and 3-month structural outcomes (r=0.807-0.835, P≤0.05). CONCLUSION: Vascular parameters derived from OCT-A can act as predictive markers for medium-term visual and structural outcomes in patients with ischemic optic neuropathy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Neuroretinal damage associated with pituitary macroadenoma: endocrine and radiological predictors and correlation with optical coherence tomography-derived biomarkers

  • Fernandez-Velasco, Diego
  • Garcia-Martin, Elena
  • Santamaria, Belen
  • Rodrigo, María Jesús
Objective: To identify endocrine and radiological tumor characteristics associated with higher risk of visual impairment. Methods: A retrospective observational study included 40 patients with pituitary macroadenoma. Variables analyzed were age, sex, disease duration, treatment, hormonal profile, tumor volume, and ophthalmic parameters: visual acuity (VA), perimetry, and retinal analysis using optical coherence tomography (OCT). Results: Surgery normalized ACTH, cortisol, IGF-1, and prolactin levels. Larger tumor volumes were observed in males, nonfunctioning tumors, nonoperated patients, and relapses. Larger tumors were associated with worse visual field, while VA remained stable. OCT showed thinning of total retina and inner retinal layers in patients with disease duration >5 years, nonfunctioning tumors, larger tumors, postoperative status, and relapse (p < 0.05). Macular ganglion cell layer thickness correlated inversely with IGF-1 and prolactin, and retinal nerve fiber layer with tumor size. The inner nuclear layer exhibited a non-linear behavior, thickening in early stages while thinning in severe injury. Conclusion: Hormonal and radiological factors are associated with visual dysfunction. OCT and perimetry detect early visual pathway damage better than VA. Non-linear behavior of the INL stand out as a potential prognostic biomarker.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

AI-Based Classification of Multiple Sclerosis Using OCT Retinal Layer Thickness Across Two Centers

  • Ortiz, Miguel
  • Dongil-Moreno, Javier
  • Rebolleda, Gema
  • Artiaga, Naiara
  • Boquete, Luciano
  • Miguel-Jimenez, Juan M.
  • Rodrigo, Maria J.
  • López-Dorado, Almudena
  • Zamora, Rosario
  • García Vicente, Eduardo
  • Sánchez-Morla, Eva M.
  • Andres-Luna, Beatriz
  • Muñoz Negrete, Francisco J.
  • Garcia-Martin, Elena
Background: The latest revision of the McDonald criteria for diagnosis of multiple sclerosis (MS) establishes that the optic nerve can serve as a fifth anatomical location within the central nervous system for diagnosis. Optical coherence tomography (OCT) images can serve as evidence for this purpose. Objective: To assess the accuracy of automated artificial-intelligence-based classification of MS patients using OCT data obtained from two different centers. Methods: OCT data were collected from two centers using standardized APOSTEL-based protocols and similar equipment. Retinal layer thicknesses—mean and standard deviation (STD) values—were analyzed in four layers and in six regions per layer per eye. A support vector machine classifier with recursive feature elimination and Shapley additive explanations value analysis was applied to identify the most relevant features and maximize classification accuracy between control subject and MS patient eyes. Results: The database drawn from two hospitals comprised 112 eyes with MS without prior history of optic neuritis and 193 eyes of control subjects. The classifier achieved maximum accuracy (0.8459) using 20 input features. The mean and STD metrics had similar importance, with the most influential layers being the ganglion cell layer, inner plexiform layer, and the inner retinal layer complex. Key regions included the papillomacular bundle and the superior temporal perimacular area. Conclusions: OCT data facilitates highly accurate MS diagnosis across different centers. Artificial intelligence assessment could facilitate automated classification. These findings provide evidence of the important role of the optic nerve in MS diagnosis.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma

  • Rodrigo, María J
  • Brugnera, Marco
  • Munuera, Ines
  • Martínez-Rincón, Teresa
  • Prats-Lluís, Catalina
  • Villacampa, Pilar
  • García Feijoo, Julián
  • Pablo, Luis E
  • Bravo Osuna, Irene
  • Garcia-Martin, Elena
  • Herrero Vanrell, María Del Rocío
  • González-Cela Casamayor, Miriam Ana
Glaucoma is a multifactorial neurodegenerative disease that affects the retina and optic nerve. The aim of this work was to reach different therapeutics targets by co-encapsulating three neuroprotective substances with hypotensive (latanoprost), antioxidant (melatonin) and anti-inflammatory (ketorolac) activity in biodegradable poly (lactic-co-glycolic acid) (PLGA) microspheres (MSs) capable of releasing the drugs for months after intravitreal injection, avoiding the need for repeated administrations. Multi-loaded PLGA MSs were prepared using the oil-in-water emulsion solvent extraction-evaporation technique and physicochemically characterized. PLGA 85:15 was the polymer ratio selected for the selected formulation. Tri-loaded MSs including vitamin E as additive showed good tolerance in retinal pigment epithelium cells after 24 h exposure (>90% cell viability). The final formulation (KMLVE) resulted in 33.58 ± 5.44 µm particle size and drug content (µg/mg MSs) of 39.70 ± 5.89, 67.28 ± 4.17 and 7.51 ± 0.58 for melatonin, ketorolac and latanoprost respectively. KMLVE were able to release in a sustained manner the three drugs over 70 days. KMLVE were injected at 2 and 12 weeks in Long-Evans rats (n = 20) after the induction of chronic glaucoma. Ophthalmological tests were performed and compared to not treated glaucomatous (n = 45) and healthy (n = 17) animals. Treated glaucomatous rats reached the lowest intraocular pressure, enhanced functionality of bipolar and retinal ganglion cells and showed greater neuroretinal thickness by optical coherence tomography (p < 0.05) compared to not treated glaucomatous rats at 24 weeks follow-up. According to the results, the tri-loaded microspheres can be considered as promising controlled-release system for the treatment of glaucoma.